LL-37 Peptide For Bodybuilding

LL-37 Peptide For Bodybuilding is a human antimicrobial peptide derived from the human cationic antimicrobial protein 18, also known as cathelicidin. Short chains of amino acids known as antimicrobial peptides are essential components of the innate immune system, serving as a first line of defense against various pathogens, including bacteria, viruses, and fungi. In the case of LL-37, it is produced by cleaving a specific portion of the hCAP18 protein. It has antimicrobial properties, meaning it can directly kill or inhibit the growth of microbes. It is a cationic peptide, meaning it carries a positive charge, which empowers it to connect with and disrupt the negatively charged membranes of microorganisms.

Shaanxi Medibridge Biotech Co., Ltd. supplies this material as research-grade powder or customized vial filling. Each batch can be supported with HPLC purity data, LC-MS identity testing, COA, and agreed packaging details. The product is supplied for research use only.

LL-37 is cleaved from a precursor protein called hCAP-18 (human cationic antimicrobial peptide-18) by the enzyme proteinase 3. The name reflects its structure: it begins with two leucine residues and contains 37 amino acids total. It is the sole cathelicidin produced by the human body. Other mammals produce dozens.

The peptide adopts an alpha-helical shape that is amphipathic. One face carries a positive charge; the other is hydrophobic. This dual nature allows it to bind negatively charged bacterial membranes while inserting into the lipid bilayer. Human cell membranes, which are neutrally charged, are largely spared at therapeutic concentrations.

The CAMP gene on chromosome 3 encodes it. Neutrophils, macrophages, dendritic cells, natural killer cells, epithelial cells, and keratinocytes all produce LL-37. It appears in skin, airways, the gastrointestinal tract, the urogenital tract, and ocular surfaces: every tissue exposed to the outside world.

LL-37 is simultaneously an antimicrobial weapon and a signaling molecule. It recruits immune cells, modulates inflammation, promotes wound healing, and disrupts biofilms.

LL-37 occupies a specific niche: antimicrobial defense combined with immune modulation. Other peptides serve different primary functions.

No single peptide covers all bases. LL-37 handles the antimicrobial and immune signaling role. BPC-157 handles tissue reconstruction. Thymosin Alpha-1 drives adaptive immune maturation. KPV provides targeted anti-inflammatory action. Stacking combines their strengths.

Chronic infections often involve biofilms, antibiotic resistance, and immune evasion. LL-37 can target all three.

1. Lyme Disease and Co-infections

LL-37 has shown activity against Borrelia burgdorferi and may help patients with chronic Lyme by penetrating biofilms and enhancing immune clearance.

2. Chronic Sinusitis and Respiratory Infections

LL-37 helps regulate mucosal immunity, reduces microbial colonization, and modulates inflammation-making it valuable in recurrent upper respiratory infections.

3. Urinary Tract Infections (UTIs)

LL-37 is naturally produced in the urinary tract and helps prevent bacterial adhesion. LL-37 therapy may be helpful for women with chronic or postmenopausal UTIs.

LL-37's antiviral properties represent a growing area of research interest:

• Influenza: Preclinical studies have reported that LL-37 can neutralize influenza virus particles and reduce viral replication in cell culture models
• HIV: Cell-culture work has reported reduced HIV-1 replication in the presence of LL-37
• Respiratory Syncytial Virus (RSV): In vitro studies have reported reduced RSV infectivity in epithelial cell models.